| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.097 | 1.781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 18.097 | 1.781 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 15.810 | 715 | 2.192 | 2.152 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 2.287 | 1.067 | -2.192 | -2.152 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 1.744 | 1.013 | -2.192 | -2.152 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medromtex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.563 | 9.042 | 2.599 | 2.552 | 2.502 | 2.455 | 2.400 | 2.408 | 2.400 | 2.387 |
| Inventories | 2.253 | 2.230 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.825 | 5.567 | 1.751 | 1.719 | 1.686 | 1.654 | 1.617 | 1.622 | 1.617 | 1.608 |
| Cash | 1.486 | 1.245 | 848 | 832 | 816 | 801 | 783 | 786 | 783 | 779 |
| Shareholders Funds | 710 | 1.716 | -505 | -496 | -487 | -477 | -467 | -468 | -467 | -464 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.854 | 7.326 | 3.105 | 3.048 | 2.989 | 2.932 | 2.867 | 2.876 | 2.867 | 2.851 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4641 - 4641" | |||||||||
| CAEN Financial Year |
4641
|
|||||||||
Comments - Medromtex Srl